Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study

AIM: Тo study the impact of 24-week therapy with nebivolol in a dose of 5 mg/day on the clinical and functional status of patients with idiopathic pulmonary hypertension (IPH), echocardiographic parameters, and blood levels of vasoactive mediators and nitric oxide (NO) metabolite. /MATERIAL AND METH...

Full description

Bibliographic Details
Main Authors: T V Martyniuk, I D Konosova, I E Chazova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2012-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31150